research Performance Evaluation of the Generative Pre-trained Transformer (GPT-4) on the Family Medicine In-Training Examination Read Performance Evaluation of the Generative Pre-trained Transformer (GPT-4) on the Family Medicine In-Training Examination
post President’s Message: ABFM’s Unwavering Commitment to Diplomates and the Specialty Read President’s Message: ABFM’s Unwavering Commitment to Diplomates and the Specialty
post “Family Medicine Was All I Ever Wanted to Do” Dr. Phillip Wagner Read “Family Medicine Was All I Ever Wanted to Do”
Home Research Research Library A Comparative Effectiveness Study on Opioid Use Disorder Prediction Using Artificial Intelligence and Existing Risk Models A Comparative Effectiveness Study on Opioid Use Disorder Prediction Using Artificial Intelligence and Existing Risk Models 2023 Author(s) Fouladvand, Sajjad, Talbert, Jeffery, Dwoskin, Linda P, Bush, Heather, Meadows, Amy L, Peterson, Lars E, Mishra, Yash R, Roggenkamp, Steven K, Wang, Fei, Kavuluru, Ramakanth, and Chen, Jin Topic(s) Role of Primary Care, and Achieving Health System Goals Keyword(s) Practice Innovations Volume IEEE Journal of Biomedical and Health Informatics Source IEEE Journal of Biomedical and Health Informatics Opioid use disorder (OUD) is a leading cause of death in the United States placing a tremendous burden on patients, their families, and health care systems. Artificial intelligence (AI) can be harnessed with available healthcare data to produce automated OUD prediction tools. In this retrospective study, we developed AI based models for OUD prediction and showed that AI can predict OUD more effectively than existing clinical tools including the unweighted opioid risk tool (ORT). Data include 474,208 patients’ data over 10 years; 269,748 were females with an average age of 56.78 years. Cases are prescription opioid users with at least one diagnosis of OUD or at least one prescription for buprenorphine or methadone. Controls are prescription opioid users with no OUD diagnoses or buprenorphine or methadone prescriptions. On 100 randomly selected test sets including 47,396 patients, our proposed transformer-based AI model can predict OUD more efficiently (AUC=0.742 ±0.021) compared to logistic regression (AUC=0.651 ±0.025), random forest (AUC=0.679 ±0.026), xgboost (AUC=0.690 ±0.027), long short-term memory model (AUC=0.706 ±0.026), transformer (AUC=0.725 ±0.024), and unweighted ORT model (AUC=0.559 ±0.025). Our results show that embedding AI algorithms into clinical care may assist clinicians in risk stratification and management of patients receiving opioid therapy. Read More ABFM Research Read all 2021 One-Third of Family Physicians Remain in Independently Owned Practice, 2017-2019 Go to One-Third of Family Physicians Remain in Independently Owned Practice, 2017-2019 2024 Underlying reasons for primary care visits where chlamydia testing was performed in the United States, 2019-2022 Go to Underlying reasons for primary care visits where chlamydia testing was performed in the United States, 2019-2022 2016 Intended vs Reported Scope of Practice–Reply Go to Intended vs Reported Scope of Practice–Reply 2019 Prevalence and Factors Associated with Family Physicians Providing E-Visits Go to Prevalence and Factors Associated with Family Physicians Providing E-Visits
Author(s) Fouladvand, Sajjad, Talbert, Jeffery, Dwoskin, Linda P, Bush, Heather, Meadows, Amy L, Peterson, Lars E, Mishra, Yash R, Roggenkamp, Steven K, Wang, Fei, Kavuluru, Ramakanth, and Chen, Jin Topic(s) Role of Primary Care, and Achieving Health System Goals Keyword(s) Practice Innovations Volume IEEE Journal of Biomedical and Health Informatics Source IEEE Journal of Biomedical and Health Informatics
ABFM Research Read all 2021 One-Third of Family Physicians Remain in Independently Owned Practice, 2017-2019 Go to One-Third of Family Physicians Remain in Independently Owned Practice, 2017-2019 2024 Underlying reasons for primary care visits where chlamydia testing was performed in the United States, 2019-2022 Go to Underlying reasons for primary care visits where chlamydia testing was performed in the United States, 2019-2022 2016 Intended vs Reported Scope of Practice–Reply Go to Intended vs Reported Scope of Practice–Reply 2019 Prevalence and Factors Associated with Family Physicians Providing E-Visits Go to Prevalence and Factors Associated with Family Physicians Providing E-Visits
2021 One-Third of Family Physicians Remain in Independently Owned Practice, 2017-2019 Go to One-Third of Family Physicians Remain in Independently Owned Practice, 2017-2019
2024 Underlying reasons for primary care visits where chlamydia testing was performed in the United States, 2019-2022 Go to Underlying reasons for primary care visits where chlamydia testing was performed in the United States, 2019-2022
2019 Prevalence and Factors Associated with Family Physicians Providing E-Visits Go to Prevalence and Factors Associated with Family Physicians Providing E-Visits
